Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer

American Journal of Clinical Pathology

Volumn 107, Issue 1, 1997, Pages 7-11

  Calzolari, Anna ^a   Chiarelli, Ilaria ^a   Bianchi, Simonetta ^a   Messerini, Luca ^a   Gallo, Oreste ^a   Porfirio, Berardino ^a,b   Mattiuz, Pier Luigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Head and neck squamous cell carcinoma; Immunohistochemistry; p53 tumor suppressor gene; Single strand conformation polymorphism analysis

Indexed keywords

DNA; MONOCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; NONSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0031042327     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.1.7     Document Type: Article

References (25)

1. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature. 1991;351:453-456.
2. Lane DP. p53: guardian of the genome. Nature. 1992;358:15-16.
3. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor DNA-complex: understanding tumorigenic mutations. Science. 1994;265:346-355.
4. Porter PL, Gown AM, Kramp SG, Coltera MD. Widespread p53 overexpression in human malignant tumors: an immunohistochemical study using methacarn-fixed, paraffin-embedded tissue. Am J Pathol. 1992;140:145-153.
5. Jenkins JR, Rudge K, Chumakov P, Currie GA. The cellular oncogene p53 can be activated by mutagenesis. Nature. 1985; 317:816-818.
6. Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A. 1990;87:7555-7559.
7. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR. Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci U S A. 1991;88:5006-5010.
8. Marks JR, Davidoff AM, Kerns BJ, et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res. 1991;51:2979-2984.
9. Melhem MF, Law JC, El-Ashmawy L, et al. Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol. 1995;146:1170-1177.
10. Allred DC, Clark G, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993;85:200-206.
11. Orita M, Suzuky Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point missense mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874-879.
12. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat. 1993;2:338-346.
13. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 1992;7:927-933.
14. Toguchida J, Yamaguchi T, Ritchie B, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 1992;52:6194-6199.
15. Donehover LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta. 1993;1155:181-205.
16. Lane DP, Benchimol S. Oncogene or anti-oncogene? Genes Dev. 1990;4:1-8.
17. Tan TH, Wallis J, Levine AJ. Identification of the p53 protein domain involved in the formation of the SV40 large T antigen p53 protein complex. J Virol. 1986;59:574-583.
18. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in non-transformed mouse cells. Mol Cell Biol. 1992;4:1689-1694.
19. Lu X, Lane DP. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes. Cell. 1993;75:765-778.
20. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA damaging agents. Oncogene. 1993;8:307-318.
21. Lane DP. The regulation of p53 function: Steiner Award Lecture. Int J Cancer. 1994;57:623-627.
22. Hall PA, McKee PH, Manage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene. 1993;8:203-208.
23. Vogelstein B, Kinzler KW. X-rays strike p53 again. Nature. 1994;370:174.
24. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J. 1990;9: 1595-1601.
25. Hurlimann J, Chaubert P, Benhattar J. p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlations between immunohistochemical and molecular biology techniques. Mod Pathol. 1994;7:423-428.